Birchview Capital, LP
data from 30/09/2025
Capitalization
$ 132.446 M
31.53 %
Performance
$ -412.232 M
-118.46 %
| Date | Ticket | Name | Weight | Capitalization | Share number | First added | Performance ($) | Performance (%) |
|---|---|---|---|---|---|---|---|---|
| 2025/09/30 | KLAC | KLA CORPORATION | 17.82% | 23.603 M $ | 21883 | 2025/06/30 | 2.898 M $ | 20.41 % |
| 2025/09/30 | BMY | BRISTOL-MYERS SQUIBB CO | 10.79% | 14.290 M $ | 316842 | 2019/03/31 | -384.796 K $ | -2.57 % |
| 2025/09/30 | CORT | CORCEPT THERAPEUTICS INC | 4.22% | 5.585 M $ | 67200 | 2015/12/31 | 652.511 K $ | 13.23 % |
| 2025/09/30 | PRTA | PROTHENA CORP PLC | 4.05% | 5.358 M $ | 549019 | 2021/06/30 | 1.664 M $ | 60.79 % |
| 2025/09/30 | STOK | STOKE THERAPEUTICS INC | 3.73% | 4.935 M $ | 210000 | 2020/03/31 | 2.552 M $ | 107.05 % |
| 2025/09/30 | QURE | UNIQURE NV | 3.47% | 4.595 M $ | 78728 | 2024/09/30 | 4.385 M $ | 318.72 % |
| 2025/09/30 | OVV | OVINTIV INC | 3.28% | 4.341 M $ | 107500 | 2020/06/30 | 250.475 K $ | 6.12 % |
| 2025/09/30 | NBIX | NEUROCRINE BIOSCIENCES INC | 3.04% | 4.028 M $ | 28690 | 2015/09/30 | 454.508 K $ | 11.69 % |
| 2025/09/30 | ACAD | ACADIA PHARMACEUTICALS INC | 2.76% | 3.649 M $ | 171000 | 2019/06/30 | -43.194 K $ | -1.07 % |
| 2025/09/30 | PTGX | PROTAGONIST THERAPEUTICS INC | 2.41% | 3.189 M $ | 48000 | 2021/03/31 | 535.680 K $ | 20.19 % |
| 2025/09/30 | CMPX | COMPASS THERAPEUTICS INC | 2.31% | 3.055 M $ | 872938 | 2025/03/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | PHR | PHREESIA INC | 2.04% | 2.698 M $ | 114700 | 2022/03/31 | -566.618 K $ | -17.36 % |
| 2025/09/30 | CSTL | CASTLE BIOSCIENCES INC | 1.90% | 2.518 M $ | 110600 | 2023/12/31 | 259.909 K $ | 11.51 % |
| 2025/09/30 | GPCR | STRUCTURE THERAPEUTICS INC | 1.65% | 2.184 M $ | 78000 | 2025/06/30 | 261.360 K $ | 35.00 % |
| 2025/09/30 | BDSX | BIODESIX INC | 1.63% | 2.165 M $ | 286804 | 2020/12/31 | 547.798 K $ | 33.84 % |
| 2025/09/30 | QUIDELORTHO CORP | 1.61% | 2.137 M $ | 72548 | 2014/12/31 | 45.705 K $ | 2.19 % | |
| 2025/09/30 | AXGN | AXOGEN INC | 1.60% | 2.124 M $ | 119078 | 2023/06/30 | 1.125 M $ | 64.42 % |
| 2025/09/30 | FOLD | AMICUS THERAPEUTICS INC | 1.51% | 1.994 M $ | 253000 | 2017/09/30 | 60.199 K $ | 37.52 % |
| 2025/09/30 | HROW | HARROW HEALTH INC | 1.46% | 1.927 M $ | 40000 | 2019/03/31 | 1.058 M $ | 57.76 % |
| 2025/09/30 | EQT | EQT CORPORATION | 1.42% | 1.884 M $ | 34619 | 2024/09/30 | -134.667 K $ | -6.67 % |
| 2025/09/30 | SLDB | SOLID BIOSCIENCES INC | 1.38% | 1.832 M $ | 296955 | 2025/03/31 | 232.398 K $ | 26.69 % |
| 2025/09/30 | OLMA | OLEMA PHARMACEUTICALS INC | 1.29% | 1.703 M $ | 174000 | 2025/06/30 | 741.019 K $ | 129.81 % |
| 2025/09/30 | CYTK | CYTOKINETICS INC | 1.24% | 1.649 M $ | 30000 | 2021/06/30 | 219.200 K $ | 66.34 % |
| 2025/09/30 | ALKS | ALKERMES PLC | 1.13% | 1.500 M $ | 50000 | 2021/03/31 | 69.500 K $ | 4.86 % |
| 2025/09/30 | FHTX | FOGHORN THERAPEUTICS INC | 1.04% | 1.378 M $ | 281730 | 2020/12/31 | 59.076 K $ | 4.04 % |
| 2025/09/30 | NVCR | NOVOCURE LTD | 1.00% | 1.319 M $ | 102100 | 2024/06/30 | -492.880 K $ | -27.42 % |
| 2025/09/30 | UTHR | UNITED THERAPEUTICS CORP | 0.95% | 1.258 M $ | 3000 | 2019/12/31 | 560.404 K $ | 45.89 % |
| 2025/09/30 | IMNM | IMMUNOME INC | 0.93% | 1.230 M $ | 105000 | 2025/06/30 | 144.600 K $ | 25.91 % |
| 2025/09/30 | MASI | MASIMO CORP | 0.92% | 1.222 M $ | 8280 | 2014/12/31 | -171.147 K $ | -12.29 % |
| 2025/09/30 | BCYC | BICYCLE THERAPEUTICS PLC | 0.90% | 1.192 M $ | 154000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | TMCI | TREACE MEDICAL CONCEPTS INC | 0.90% | 1.187 M $ | 176947 | 2024/09/30 | 146.866 K $ | 14.12 % |
| 2025/09/30 | KINIKSA PHARMACEUTICALS LTD | 0.88% | 1.165 M $ | 30000 | 2021/06/30 | 334.799 K $ | 40.33 % | |
| 2025/09/30 | OUTSET MEDICAL INC | 0.84% | 1.110 M $ | 78584 | 2024/06/30 | -176.032 K $ | -26.50 % | |
| 2025/09/30 | INBX | INHIBRX BIOSCIENCES INC | 0.81% | 1.068 M $ | 31698 | 2024/06/30 | 623.255 K $ | 136.02 % |
| 2025/09/30 | DCGO | DOCGO INC | 0.78% | 1.039 M $ | 764062 | 2021/12/31 | -160.453 K $ | -13.38 % |
| 2025/09/30 | NTLA | INTELLIA THERAPEUTICS INC | 0.78% | 1.036 M $ | 60000 | 2025/06/30 | 473.399 K $ | 84.12 % |
| 2025/09/30 | TVTX | TRAVERE THERAPEUTICS INC | 0.78% | 1.029 M $ | 43060 | 2023/03/31 | 937.299 K $ | 61.49 % |
| 2025/09/30 | PHAT | PHATHOM PHARMACEUTICALS INC | 0.76% | 1.000 M $ | 85000 | 2025/06/30 | 54.499 K $ | 22.73 % |
| 2025/09/30 | SRRK | SCHOLAR ROCK HOLDING CORP | 0.73% | 968.240 K $ | 26000 | 2024/12/31 | 29.120 K $ | 5.14 % |
| 2025/09/30 | XENE | XENON PHARMACEUTICALS INC | 0.64% | 843.150 K $ | 21000 | 2022/06/30 | 185.849 K $ | 28.27 % |
| 2025/09/30 | KALV | KALVISTA PHARMACEUTICALS INC | 0.62% | 816.060 K $ | 67000 | 2019/09/30 | 58.289 K $ | 7.70 % |
| 2025/09/30 | HALO | HALOZYME THERAPEUTICS INC | 0.56% | 740.734 K $ | 10100 | 2022/12/31 | 213.200 K $ | 40.98 % |
| 2025/09/30 | AXSM | AXSOME THERAPEUTICS INC | 0.55% | 728.700 K $ | 6000 | 2024/03/31 | 102.360 K $ | 16.34 % |
| 2025/09/30 | FCX | FREEPORT-MCMORAN CL-B | 0.53% | 707.689 K $ | 18044 | 2025/06/30 | -74.476 K $ | -9.53 % |
| 2025/09/30 | RARE | ULTRAGENYX PHARMACEUTICAL INC | 0.50% | 661.760 K $ | 22000 | 2024/12/31 | -113.040 K $ | -17.27 % |
| 2025/09/30 | PACB | PACIFIC BIOSCIENCES OF CALIFORNIA INC | 0.48% | 640.000 K $ | 500000 | 2025/06/30 | 16.000 K $ | 3.23 % |
| 2025/09/30 | APGE | APOGEE THERAPEUTICS INC | 0.48% | 635.680 K $ | 16000 | 2025/03/31 | -59.200 K $ | -8.52 % |
| 2025/09/30 | ELUTIA INC | 0.48% | 633.088 K $ | 711175 | 2021/06/30 | -1.263 M $ | -55.04 % | |
| 2025/09/30 | VYGR | VOYAGER THERAPEUTICS INC | 0.48% | 630.067 K $ | 134918 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | ATEC | ALPHATEC HOLDINGS INC | 0.36% | 479.820 K $ | 33000 | 2022/09/30 | 113.519 K $ | 30.99 % |
| 2025/09/30 | BBIO | BRIDGEBIO PHARMA INC | 0.34% | 451.255 K $ | 8688 | 2025/06/30 | 43.799 K $ | 20.29 % |
| 2025/09/30 | AVTX | AVALO THERAPEUTICS INC | 0.30% | 394.010 K $ | 31000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | GH | GUARDANT HEALTH INC | 0.28% | 374.880 K $ | 6000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | PHVS | PHARVARIS N V | 0.28% | 370.433 K $ | 14847 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | ZBIO | ZENAS BIOPHARMA INC | 0.28% | 366.300 K $ | 16500 | 2024/12/31 | 206.415 K $ | 129.10 % |
| 2025/09/30 | GOSS | GOSSAMER BIO INC | 0.27% | 363.403 K $ | 138176 | 2021/09/30 | 193.446 K $ | 113.82 % |
| 2025/09/30 | APLS | APELLIS PHARMACEUTICALS INC | 0.24% | 316.820 K $ | 14000 | 2019/06/30 | 74.480 K $ | 30.73 % |
| 2025/09/30 | VTYX | VENTYX BIOSCIENCES INC | 0.23% | 307.352 K $ | 98827 | 2021/12/31 | 27.935 K $ | 45.33 % |
| 2025/09/30 | CADL | CANDEL THERAPEUTICS INC | 0.23% | 306.000 K $ | 60000 | 2024/12/31 | 2.400 K $ | 0.79 % |
| 2025/09/30 | KIDS | ORTHOPEDIATRICS CORP | 0.22% | 296.480 K $ | 16000 | 2025/03/31 | -76.699 K $ | -13.73 % |
| 2025/09/30 | TELA | TELA BIO INC | 0.17% | 230.950 K $ | 155000 | 2024/12/31 | -69.750 K $ | -23.20 % |
| 2025/09/30 | NKTR | NEKTAR THERAPEUTICS | 0.17% | 228.795 K $ | 4021 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | XLV | HEALTHCARE SELECT SECTOR SPDR FUND | 0.16% | 208.477 K $ | 1498 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | KARYOPHARM THERAPEUTICS INC | 0.14% | 183.022 K $ | 27985 | 2018/06/30 | 62.406 K $ | 51.74 % | |
| 2025/09/30 | APLT | APPLIED THERAPEUTICS INC | 0.10% | 136.103 K $ | 225000 | 2025/06/30 | 82.264 K $ | 94.44 % |
| 2025/09/30 | CGEM | CULLINAN THERAPEUTICS INC | 0.09% | 118.600 K $ | 20000 | 2021/03/31 | -32.000 K $ | -21.25 % |
| 2025/09/30 | IFRX | INFLARX NV | 0.05% | 67.000 K $ | 50000 | 2020/03/31 | 27.500 K $ | 69.62 % |
| 2025/09/30 | ALMS | ALUMIS INC | 0.03% | 39.900 K $ | 10000 | 2024/09/30 | 9.900 K $ | 33.00 % |
| 2025/09/30 | ZNTL | ZENTALIS PHARMACEUTICALS INC | 0.02% | 25.670 K $ | 17000 | 2023/12/31 | 5.950 K $ | 30.17 % |
| 2025/09/30 | TXG | 10X GENOMICS INC | 0.00% | 0.000 $ | 0 | 2023/06/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | WVE | WAVE LIFE SCIENCES LTD | 0.00% | 0.000 $ | 0 | 2023/12/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | XNCR | XENCOR INC | 0.00% | 0.000 $ | 0 | 2015/03/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 0.00% | 0.000 $ | 0 | 2024/12/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | BCRX | BIOCRYST PHARMACEUTICALS INC | 0.00% | 0.000 $ | 0 | 2019/06/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | COGT | COGENT BIOSCIENCES INC | 0.00% | 0.000 $ | 0 | 2025/06/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | APTEVO THERAPEUTICS INC | 0.00% | 0.000 $ | 0 | 2025/06/30 | 0.000 $ | 0.00 % | |
| 2025/09/30 | BPMC | BLUEPRINT MEDICINES CORP | 0.00% | 0.000 $ | 0 | 2024/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | ACCELERATE DIAGNOSTICS INC | 0.00% | 0.000 $ | 0 | 2014/12/31 | 0.000 $ | 0.00 % | |
| 2025/09/30 | NPCE | NEUROPACE INC | 0.00% | 0.000 $ | 0 | 2024/12/31 | 0.000 $ | 0.00 % |